Biogen’s business development team may have been busy in recent years, but CEO Christopher Viehbacher is easing off the acquisitions for a while.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Biogen’s business development team may have been busy in recent years, but CEO Christopher Viehbacher is easing off the acquisitions for a while.